Key result
Pretreatment with cromolyn sodium prior to reperfusion protected the small intestine mucous from ischemia-reperfusion damage by inhibiting intestinal mucosal mast cell degranulation.
Why the study?
Does Cromolyn Sodium pretreatment attenuate intestinal ischemia-reperfusion injury in rats?
RCT (n=32)
randomly divided
Does Cromolyn Sodium pretreatment attenuate intestinal ischemia-reperfusion injury in rats?
Cromolyn sodium pretreatment protects against intestinal ischemia-reperfusion injury in rats by inhibiting intestinal mucosal mast cell degranulation.
Answers are grounded in this paper and cite their sources.
Cromolyn pretreatment attenuates rat intestinal ischemia-reperfusion injury; leaves open translation to human therapy.
AIM: To investigate the effects of Cromolyn Sodium (CS) pretreated prior to reperfusion on the activity of intestinal mucosal mast cells (IMMC) and mucous membrane of the small intestine in ischemia-reperfusion (IR) injury of rats. METHODS: Thirty-two Sprague-Dawley (SD) rats were randomly divided into four groups: sham group (group S), model group (group M), high and low dosage of CS groups, (treated with CS 50 mg/kg or 25 mg/kg, group C1 and C2). Intestinal IR damage was induced by clamping the superior mesenteric artery for 45 min followed by reperfusion for 60 min. CS was intravenouly administrated 15 min before reperfusion. Ultrastructure and counts of IMMC, intestinal structure, the expression of tryptase, levels of malondisldehyde (MDA), TNF-alpha, histamine and superoxide dismutase (SOD) activity of the small intestine were detected at the end of experiment. RESULTS: The degranulation of IMMC was seen in group M and was attenuated by CS treatment. Chiu's score of group M was higher than the other groups. CS could attenuate the up-regulation of the Chiu's score, the levels of MDA, TNF-alpha, and expression of tryptase and the down-regulation of SOD activity and histamine concentration. The Chiu's score and MDA content were negatively correlated, while SOD activity was positively correlated to the histamine concentration respectively in the IR groups. CONCLUSION: Pretreated of CS prior to reperfusion protects the small intestine mucous from ischemia-reperfusion damage, the mechanism is inhibited IMMC from degranulation.
No takes yet. Share an insight, caveat, or question.
Ziqing Hei (2007) conducted an RCT in intestinal ischemia-reperfusion injury (n=32). Cromolyn Sodium (CS) vs. model group and sham group was evaluated on degranulation of IMMC, Chiu's score, MDA, TNF-alpha, tryptase, SOD activity, and histamine concentration. Pretreatment with cromolyn sodium prior to reperfusion protected the small intestine mucous from ischemia-reperfusion damage by inhibiting intestinal mucosal mast cell degranulation.
Synapse has enriched 10 related papers. Consider them for comparative context: